Join to view full profile
1365 Clifton Rd NEAtlanta, GA 30322
Phone+1 404-778-1900
Dr. Lawson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Lawson, MD is an oncologist based in Atlanta, GA who specializes in Hematologic Oncology and Melanoma. He studied at Emory University School of Medicine and completed a residency and fellowship there in Internal Medicine and Hematology and Medical Oncology respectively. His primary interest has been melanoma and cutaneous malignanciec. Recently he has also become interested in rudeness, bullying, and harassment among healthcare providers and how we might improve how we communicate with each other. Dr. Lawson has numerous significant publications, notably in JID Innovations, New England Journal of Medicine, Journal of Clinical Oncology, BMJ Open Quality and The Lancet Oncology. He has been involved in several clinical trials, particularly involving immunotherapy and melanoma and cutaneous malignancies. Dr. Lawson has received several awards including America's Top Doctors and Top Doctors for Cancer from Castle Connolly, and a Top MD recognition from Consumers Checkbook. He has recently been recognized as a Fellow of the American Association for the Advancement of Science
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1979- Emory University School of MedicineResidency, Internal Medicine, 1974 - 1977
- Emory University School of MedicineClass of 1974
Certifications & Licensure
GA State Medical License 1975 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015
Clinical Trials
- A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and Start of enrollment: 1999 Dec 01
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma Start of enrollment: 2005 Oct 04
- Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment Start of enrollment: 2006 Oct 06
Publications & Presentations
PubMed
- B-cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.Kavita M Dhodapkar, Antonio Matera, Alyssa M Duffy, Azmain Taz, Renee Julia Manalo
The Journal of Clinical Investigation. 2026-08-25 - Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.Howa Yeung, Krittin J Supapannachart, Sandy Francois, Colin H Adler, Ragini R Kudchadkar
JID Innovations. 2023-11-01 - 3 citationsMetastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report.Alyssa R Cruse, Alexa J Basilio, David H Lawson
Case Reports in Oncology. 2023-10-26
Journal Articles
- Prognostic Gene Expression Profiling in Cutaneous MelanomaDouglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Kari L..., JAMA Dermatology
- T Cell Receptor Sequencing of Activated CD8 T Cells in the Blood Identifies Tumor-Infiltrating Clones That Expand After PD-1 Therapy and Radiation in a Melanoma PatientJonathan J Masor, Juan Sarmiento, Walter J Curran, David H Lawson, Rafi Ahmed, Yue Xue, Cancer Immunology, Immunotherapy
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
Cancer Spread to Jimmy Carter's Brain 9 Years Ago. Here's How He's Lived so LongSeptember 30th, 2024- Cancer Treatment Extended Jimmy Carter’s Life Before His 100th BirthdaySeptember 30th, 2024
- Gift Honoring David Lawson, MD, Endows Cancer Research Professorship at WinshipFebruary 4th, 2022
Grant Support
- Radioimmunoassay In The Evaluation Of Response To Hypophysectomy In MelanomaNational Center For Research Resources1985
- Pharmacokinetics And Toxicity Of High Dose Methotrexate With Leucovorin RescueNational Center For Research Resources1985
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: